The Cancer Drug Management Programme was established by the NCCP to develop and improve the care provided to patients receiving treatment with cancer drugs.
A national management system for cancer drugs was set up so that the health service can continue to provide quality cancer treatment to patients within difficult budgetary conditions. The national management system facilitates:
- National oversight of the spend on high-cost cancer drugs, allowing for coordinated planning and, potentially, national approaches to provision of cancer drugs.
- Detailed information about drug utilisation as well as cancer incidence and prevalence.
- A mechanism for assuring adherence to national drug protocols, which is a key quality and patient safety objective for the National Cancer Control Programme (NCCP).
- A coordinated system for HSE and NCCP, hospitals and PCRS in relation to high-cost cancer drugs.
More information is available by clicking the links below:
The Oncology Drugs Management System
Cancer Drugs approved for Reimbursement
The Cancer Drug Management Programme and Clinical Trials